Herbal Medicine
Time-tested Thai formulas for modern herbal products
with a long history of use, each with its composition, indications and dosage already set by Thailand's Ministry of Public Health. Notify them as listed, or work with TIBD to develop them into registered herbal medicines (Category B) and evidence-based herbal health products (Category C).
Types of herbal products
Notifiable formulas: 2 product types, 3 lists
The Herbal Products Act B.E. 2562 (2019) divides herbal products into herbal medicines and herbal products for health. The announcement lists the formulas of each type in its annexes.
Herbal medicine · List 1
Thai traditional medicine formulas
Multi-ingredient formulas from Thai traditional medicine texts. The label text is called the indication (sapphakhun).
208formulas in the list
58as capsules
Herbal medicine · List 2
Herbal-derived medicines
Single-herb medicines such as turmeric, andrographis and centella. The label text is called the indication.
15formulas in the list
10as capsules
Herbal product for health · List 3
Herbal products for health
Products for health care such as black ginger, garlic and triphala. The label text is called a health claim.
88formulas in the list
38as capsules
Capsule counts follow the announcement. In the formula search below you can filter every list by dosage form.
Development pathway
From a listed formula to developed herbal medicines and health products
The Thai FDA accepts a documented history of traditional use as safety evidence, so these formulas are a starting point that does not have to be proven from scratch. The further a product moves from the listed formula, the more data it needs, and the more it becomes the brand's own.
Step 1 · Notification
Use a listed formula
Name, formula and label text exactly match a formula in List 1, 2 or 3
Evidence usedThe formula and wording set by the announcement
On this page:
Notification B.E. 2564 (2021), clause 4
Step 2 · Detailed notification
Adapt it into your own brand
Differs from the listed formula only in these items
- Product name
- Non-essential ingredients
- Manufacturing process
- Dose, not above the maximum in the list
- Indications or claims within the original scope
- Pack size
Evidence usedShow that quality, efficacy and safety are not affected
Notification B.E. 2564 (2021), clause 5
Step 3 · Formula registration
Develop a new product
Category B (ข.) · Developed herbal medicines
- B1Herbal medicines with developed manufacturing
- B2Generally accepted herbal medicines
- B3Researched and developed herbal medicines
- B4New herbal medicines
Category C (ค.) · Herbal products for health
- C1Based on traditional knowledge
- C2Developed from traditional knowledge
- C3Based on scientific knowledge
- C4Herbal cosmeceuticals
Efficacy evidence the Thai FDA considersTraditional texts · bibliographic evidence of well-established medicinal use · scientific data and clinical research
Notification B.E. 2564 (2021), clause 6 · Thai FDA guidance, 30 Apr 2026
Development stages, and who in the group handles each
Stages as set out by the Thai FDA Herbal Products Division. Skip the ones your product does not need.
Pre-formulation
Study the raw material, marker compounds and extraction method before formulating
TIBDVISBIOFormulation & Stability
Develop the formula and dosage form, and test stability
TIBDVISBIOPre-clinical
In vitro and cell-based testing
Clinical trial
Studies in human volunteers
Dossier and FDA filing
Compile the quality, safety and efficacy data
TIBD
Test batches and commercial batches can be made at K-API, the group's plant licensed by the Thai FDA to manufacture herbal products. Products made for clinical research are exempt from formula registration, but the Thai FDA must be notified with the required documents first.
Herbal compresses, herbs for foot soaking and herbs for steam baths are exempt from registration, detailed notification and notification under Notification No. 5, B.E. 2569 (2026), effective 1 September 2026.
Formula search
Notifiable formulas in every dosage form
Select a formula to see its ingredients, parts used, weights and indications. Formula names and indications are a reference translation; the Thai announcement is the legal text, and dosage, contraindications and warnings are on the Thai page.
Dosage form
What it is used forgrouped by the indications in the announcement
More filtersList · single herb/multi-herb · part used
List
Ingredients
Part used
Card images are AI-generated illustrations based on each formula in the announcement and the crude drug descriptions in the Thai Herbal Pharmacopoeia. They do not show actual products.
formulas containing cannabis, hemp or kratom are not shown, because they need additional permits under specific laws.
How TIBD can help
From a listed formula to a product ready to file
Once you have chosen a formula, the remaining work is making the raw materials, formula and documents match the announcement. The TIBD team does this work together with brand owners.
Formula review and filing documents
We check whether your formula and label text qualify for notification, detailed notification or registration, then prepare the data and supporting documents for the filing.
Herbal capsule stability testing
Stability testing of hard capsules and herbal tablets, with a stability data package for the Thai FDA filing.
From 15,000 THB
Extraction and formulation
For formulas that use extracts, or brands adapting a listed formula, our R&D team helps choose the extraction method, develop the formula and mask bitterness.
Have a formula in mind, or still choosing?
Tell the team what product you want to make. We will help you see which formulas fit and which filing route applies.
Manufacturing in the group
Herbal formulas made at K-API, Kasetsart University
K-API Co., Ltd., a joint venture with KU Universe of Kasetsart University within the TIBD group, holds a herbal product manufacturing licence from the Thai FDA. Extraction, production and the notification dossier can all be handled within the group.
Licensed by the Thai FDA to manufacture herbal products
Production takes place at the K-API plant, Kasetsart University, from extraction to finished product. The TIBD team helps you choose a formula and prepare the notification documents.
Capsules: an application to add capsules to the licence is in progress. In the meantime we can plan the formula and prepare the documents.
Real photographs of the K-API plant
Data sources
- Notification of the Ministry of Public Health on the names, types and characteristics of herbal products whose production or import for sale requires formula registration, detailed notification or notification, and the names, quantities and conditions of substances that may be used in herbal products eligible for notification, B.E. 2564 (2021) (Royal Thai Government Gazette, Vol. 138, Special Part 116 Ngor, 31 May 2021), clauses 4–6
- Notification on the same subject (No. 4), B.E. 2569 (2026) (Royal Thai Government Gazette, Vol. 143, Special Part 36 Ngor, 9 February 2026), which repeals the former Lists 1, 2 and 3 and replaces them with the lists annexed to it. Notification and detailed notification certificates issued before it took effect remain valid until they expire.
- Notification on the same subject (No. 5), B.E. 2569 (2026) (Royal Thai Government Gazette, Vol. 143, Special Part 207 Ngor, 31 August 2026), which amends clause 7 on exempt products without changing the formula lists.
- Herbal Products Division, Thai Food and Drug Administration. Guidance on registering herbal products with the Thai FDA (presentation, 30 April 2026) open file. Used in the development pathway: Categories B1–B4 and C1–C4, efficacy evidence and development stages.
The formula names and indications on this page are TIBD's reference translation of the Thai announcement, for product planning only. They are not medical advice. The Thai text in the Royal Gazette is the legal text: check it and the current Thai FDA conditions before filing.
Product and ingredient illustrations on this page are AI-generated and do not show actual products. Photos of the K-API plant are real photographs.